Here is the second part of my thoughts from last week’s initial blog post about the article on the use of SaaS in the pharmaceutical industry. The article was written in PharmaVOICE and was titled Software as a Service Gaining Traction. This article documents the comments of thought leaders in the pharmaceutical industry concerning the adoption of SaaS software by pharmaceutical companies. The complete article can be found at http://www.pharmavoice.com/archives/article.esiml?id=2012. My blog post will document what I believe are the most relevant and thought provoking comments.
THOUGHT LEADERS WHO PARTICIPATED
Ken Arbadji. VP, StayinFront, a global provider of CRM and decision-support solutions. For more information, visit stayinfront.com.
Leila Daiuto. Sales Director, Axentis, a part of ARC Logics, a Wolters Kluwer business, which provides governance, risk, and compliance management software. For more information, visit axentis.com.
Jamie Duke. Chief Operating Officer, SciQuest Inc., which provides global procurement automation and supplier enablement solutions. For more information, visit sciquest.com.
Dominic John. Director of Software Marketing, Symyx Technologies Inc., a provider of software solutions for the electronic laboratory environment that transform scientific R&D. For more information, visit symyx.com.
DeWayne Manning, R.Ph. President, DiseaseTrak, a specialty healthcare services company that creates and manages patient management solutions. For more information, visit diseasetrak.com.
Ken Parmelee. Director of Application Development, Antenna Software, which enables organizations to design, build, deploy, and manage secure mobile applications. For more information, visit
Jo Ann Saitta. Senior VP, PDI Inc., which provides commercialization services for established and emerging biopharmaceutical companies. For more information, visit pdi-inc.com.
Nagaraja Srivatsan. VP and Head of Life Sciences, North America, Cognizant, which offers IT, consulting, analytics, and business process outsourcing services to global pharma, biotech, and medical-device companies. For more information, visit cognizant.com.
Matt Wallach. Executive VP and General Manager, Veeva Systems, which develops SaaS applications for the global life-sciences industry. For more information, visit veevasystems.com.
Steve Webb. Chairman, Interactive Medica, which supplies SaaS applications to the life-sciences industry. For more information, visit interactivemedica.com.
Mike Wexler. Founding Principal, Biltmore Technologies Inc., which offers SaaS business intelligence solutions and technology consulting to sales and marketing divisions of pharmaceutical and biotech companies. For more information, visit biltmoretech.com or e-mail email@example.com.
Cost – Here is an overview of how these thought leaders believe SaaS can affect costs in pharma:
Flexibility – and finally, how SaaS can increase flexibility:
About the Author
John McGee is the founder of OptifiNow. OptifiNow, is an industry leader in SaaS based solutions designed to optimize the effectiveness of the sales force. Although OptifiNow’s platform is modular in design it offers a fully integrated solution that allows a company to define and automate a company specific benchmark sales processes and provide all the required tools that includes Lead Management, CRM, and Sales Enablement all designed by and tailored for use by the sales force. OptifiNow enables multi-channel timely, relevant, brand and regulatory compliant communication. OptifiNow supports Direct Mail, Email, Digital Print, SMS, Social, and Telephonic channels of communication.
OptifiNow is a powerful all-in-one platform that helps enterprise teams easily handle the entire sales cycle – for results you can measure on your bottom line.